CN Patent

CN118338905A — Wee1激酶抑制剂在治疗癌症中的应用

Assigned to Impact Therapeutics Inc · Expires 2024-07-12 · 2y expired

What this patent protects

本发明涉及Wee1激酶抑制剂在治疗癌症中的应用。具体而言，本发明提供Wee1激酶抑制剂在制备治疗具有FBXW7或CHD4突变的肿瘤患者的药物中的应用。

USPTO Abstract

本发明涉及Wee1激酶抑制剂在治疗癌症中的应用。具体而言，本发明提供Wee1激酶抑制剂在制备治疗具有FBXW7或CHD4突变的肿瘤患者的药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN118338905A
Jurisdiction
CN
Classification
—
Expires
2024-07-12
Drug substance claim
No
Drug product claim
No
Assignee
Impact Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.